Due to rising public health concerns regarding COVID-19, the March 21st IPCSG meeting has been postponed.  At this time we do not know when we will resume our normal meeting schedule at the Sanford Burnham Prebys Medical Discovery Institute auditorium, but we are looking into other avenues for live-streaming our presenters to your computer.  Stay tuned

San Diego Sexual Medicine, under the leadership of Dr. Irwin Goldstein, is planning a clinical trial in the near future in men with incontinence.  They will be studying a device called  BTL Emsella®, which is intended to provide entirely non-invasive electromagnetic stimulation of pelvic floor musculature for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of male (or female) urinary incontinence.  The patient sits on a chair-like device, fully clothed, and receives over 10,000 muscle stimulations in a 30-minute session. 

Visit https://bodybybtl.com/solutions/pelvic-suite/btl-emsella/ for more information about the device.

Men aged 21-80 who have stress urinary incontinence (leaking with sneezing / coughing / jumping), urge urinary incontinence (can’t hold it in as you approach the bathroom), or mixed incontinence may be interested in participating. They have to be sexually active at the time of the trial and willing to continue being sexually active.  They cannot have surgery planned for the time of the trial, or have an untreated malignancy.  Because the device is essentially a magnet, they cannot have a pacemaker or implanted device that can be damaged by the magnet, such as a defibrillator, neurostimulator or drug pump.

If anyone is interested in participating, they should reach out directly to JoAnna at 619-265-7695.  She can discuss the trial and ask specific questions to see if the person qualifies to come in to screen.  But simply put, each potential subject would be screened, and if qualified move into treatment 4 weeks later.  Treatment would be twice a week for 3 weeks in a row.  Then he would come back 4 weeks later and again 8 weeks after that.  At that point (18 weeks after screening), he would be unblinded. Two out of three men will be on active treatment the first time around. Those people who had been treated with sham would then start their real treatments, twice a week for 3 weeks, then come back for the 2 follow up visits.  So everyone gets treated in the end.  And anyone interested in this therapy but not through a clinical trial can pay for treatment as a patient.

Information provided by Sue W. Goldstein, CCRC, CSE, IF   (Certified Clinical Research Coordinator and Certified Sexuality Educator); Clinical Research Manager at San Diego Sexual Medicine, 5555 Reservoir Drive, Suite 300, San Diego, CA 92120

Phone: 619 265-8865   

suewgoldstein@gmail.com 

http://www.SanDiegoSexualMedicine.com